Cascade Biotechnology INC | Complement Therapeutics; novel approach to CNS/PNS disease management using the innate complement system.

Daniel E. Benjamin Ph.D.

Daniel E. Benjamin Ph.D. is the Chief Executive Officer (CEO) of our company. With his extensive knowledge and experience, he leads the organization in setting strategic goals and implementing effective business strategies. He oversees the overall operations of the company, including financial performance, resource allocation, and risk management. Under his leadership, the company has achieved significant growth and success.

Read More  

Edwin Holland B.A.

Chief Operating Officer, V.P. Business Development

David Frizinger Ph.D.

Chief Biotechnology Officer

Duncan Taylor Ph.D.

Consultant to Business Development